LUNGevity Foundation Amplifies Efforts to Improve Lung Cancer Patient Access to Comprehensive Biomarker Testing through New Awareness Campaign
New campaign aims to ensure there is "No One Missed" in receiving comprehensive biomarker testing and a fully informed diagnosis for the appropriate treatment
News provided by
Share this article
Share this article
WASHINGTON, Feb. 18, 2021 /PRNewswire/ -- LUNGevity Foundation will be launching a new lung cancer campaign called
No One Missed, created to drive essential comprehensive biomarker testing in non-small cell lung cancer (NSCLC). Guideline-recommended comprehensive biomarker testing can reveal vital information to help identify the appropriate individualized treatment plan for each NSCLC patient.